Equity Overview
Price & Market Data
Price: $3.33
Daily Change: +$0.01 / 0.30%
Range: $3.33 - $3.33
Market Cap: $2,883,134
Volume: 255
Performance Metrics
1 Week: -8.29%
1 Month: 1.22%
3 Months: -10.14%
6 Months: -56.88%
1 Year: -75.43%
YTD: -51.60%
Company Details
Employees: 3
Sector: Health technology
Industry: Pharmaceuticals: major
Country: United States
Details
Protagenic Therapeutics, Inc., a biopharmaceutical company, engages in the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. The company's lead compound comprises PT00114, a synthetic form of teneurin carboxy-terminal associated peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. Protagenic Therapeutics, Inc. is headquartered in New York, New York.